Morisset Valerie has filed 26 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 10201 shares of Climb Bio, Inc. ($CLYM) on July 19, 2024.
Activity breakdown: 0 open-market purchases and 14 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 19, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 10201 | $7.09 | 150,322.0000 | 0 | 6.35% | 0.00% |
| July 19, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $7.24 | 100,322.0000 | 0 | 33.26% | 0.00% |
| July 22, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 39005 | $8.07 | 61,317.0000 | 0 | 38.88% | 0.00% |
| July 22, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 30000 | $7.98 | 31,317.0000 | 0 | 48.93% | 0.00% |
| July 17, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 3207 | $6.91 | 199,099.0000 | 0 | 1.59% | 0.00% |
| July 18, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 38576 | $6.93 | 160,523.0000 | 0 | 19.38% | 0.00% |
| July 16, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $7.13 | 202,306.0000 | 0 | 19.82% | 0.00% |
| July 12, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $7.07 | 294,683.0000 | 0 | 14.51% | 0.00% |
| July 15, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 42377 | $7.01 | 252,306.0000 | 0 | 14.38% | 0.00% |
| July 9, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 5931 | $6.66 | 444,683.0000 | 0 | 1.32% | 0.00% |
| July 10, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $6.83 | 394,683.0000 | 0 | 11.24% | 0.00% |
| July 11, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $7.11 | 344,683.0000 | 0 | 12.67% | 0.00% |
| July 5, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 12342 | $7.06 | 450,614.0000 | 0 | 2.67% | 0.00% |
| July 1, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Common Stock | 7649 | $0.00 | 512,956.0000 | 0 | 1.51% | 0.00% |
| July 3, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | S | Common Stock | 50000 | $6.76 | 462,956.0000 | 0 | 9.75% | 0.00% |
| July 1, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Stock Option (Right to Buy) | 7649 | $0.00 | 10,198.0000 | 0 | 42.86% | 0.00% |
| April 5, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Common Stock | 17847 | $0.00 | 505,307.0000 | 0 | 3.66% | 0.00% |
| April 5, 2024 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Stock Option (Right to Buy) | 17847 | $0.00 | 28,046.0000 | 0 | 38.89% | 0.00% |
| Sept. 20, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Common Stock | 5431 | $0.00 | 472,163.0000 | 0 | 1.16% | 0.00% |
| Sept. 20, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Common Stock | 15297 | $0.00 | 487,460.0000 | 0 | 3.24% | 0.00% |
| Sept. 20, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Stock Option (Right to Buy) | 5431 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 20, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D AND CSO | M | Stock Option (Right to Buy) | 15297 | $0.00 | 45,893.0000 | 0 | 25.00% | 0.00% |
| March 10, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D and CSO | M | Common Stock | 255219 | $0.00 | 405,541.0000 | 0 | 169.78% | 0.00% |
| March 10, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D and CSO | M | Common Stock | 61191 | $0.00 | 466,732.0000 | 0 | 15.09% | 0.00% |
| March 10, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D and CSO | M | Stock Option (Right to Buy) | 255219 | $0.00 | 5,431.0000 | 0 | 97.92% | 0.00% |
| March 10, 2023 | Climb Bio, Inc. | $CLYM | Morisset Valerie | EVP, R&D and CSO | M | Stock Option (Right to Buy) | 61191 | $0.00 | 61,190.0000 | 0 | 50.00% | 0.00% |